Journal article
A microRNA-21-mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis
RY Kim, KP Sunkara, KR Bracke, AG Jarnicki, C Donovan, AC Hsu, A Ieni, EL Beckett, I Galvão, S Wijnant, FLM Ricciardolo, A Di Stefano, TJ Haw, G Liu, AL Ferguson, U Palendira, PA Wark, G Conickx, P Mestdagh, GG Brusselle Show all
Science Translational Medicine | Published : 2021
Abstract
Chronic obstructive pulmonary disease (COPD) is the third leading cause of morbidity and death worldwide. Inhalation of cigarette smoke (CS) is the major cause in developed countries. Current therapies have limited efficacy in controlling disease or halting its progression. Aberrant expression of microRNAs (miRNAs) is associated with lung disease, including COPD. We performed miRNA microarray analyses of the lungs of mice with CS-induced experimental COPD. miR-21 was the second highest up-regulated miRNA, particularly in airway epithelium and lung macrophages. Its expression in human lung tissue correlated with reduced lung function in COPD. Prophylactic and therapeutic treatment with a spec..
View full abstractGrants
Awarded by National Health and Medical Research Council of Australia
Awarded by Concerted Research Action of the Ghent University (BOF/GOA)
Awarded by Fund for Scientific Research in Flanders (FWO Vlaanderen)
Awarded by Fund for Scientific Research in Flanders (EOS contract)
Funding Acknowledgements
This work was supported by grants and fellowships from the National Health and Medical Research Council of Australia (1003593 to P.M.H. and 1079187 to P.M.H.), the University of Newcastle, the Hunter Medical Research Institute (to P.M.H.), the Concerted Research Action of the Ghent University (BOF/GOA, 01G02714 to K.R.B.), the Fund for Scientific Research in Flanders (FWO Vlaanderen, G052518N and EOS contract G0G2318N to K.R.B.), and fellowships from the Lung Foundation of Australia (to R.Y.K. and A.G.J.).